Loading clinical trials...
Loading clinical trials...
Double-blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of the Manremyc® Food Supplement to Prevent SARS-CoV-2 Infection
Conditions
Interventions
Manremyc
Placebo
Locations
5
Spain
CAP Cornellà (La Gavarra)
Cornellà de Llobregat, Barcelona, Spain
CAP Maresme
Mataró, Barcelona, Spain
Cap Sant Fèlix
Sabadell, Barcelona, Spain
EAP Riu Nord
Santa Coloma de Gramenet, BArcelona, Spain
Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona,
Badalona, Spain
Start Date
July 14, 2020
Primary Completion Date
September 1, 2020
Completion Date
December 1, 2021
Last Updated
July 15, 2020
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Reig Jofre Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions